ETF Managers Group’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$190K Buy
+66,326
New +$231K 0.01% 588
2022
Q4
Sell
-96,060
Closed -$561K 567
2022
Q3
$561K Buy
96,060
+7,248
+8% +$63.9K 0.02% 367
2022
Q2
$826K Buy
+88,812
New +$795K 0.02% 254

Other funds holding DRTS

ETF Managers Group's DRTS Position: Q1 2023 in Review

ETF Managers Group opened a new position in Alpha Tau Medical (DRTS) in Q1 2023: 66,326 shares worth $190K. The stake represents 0.01% of the portfolio and ranks #588 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in DRTS as recently as Q3 2022.

ETF Managers Group first reported a position in DRTS in Q2 2022 and has held it in 3 quarters since. The position peaked at $826K in Q2 2022. 16 funds tracked by Wall St. Rank hold DRTS as of Q1 2023.

  • ETF Managers Group held 66,326 shares of Alpha Tau Medical worth $190K as of Q1 2023.
  • Alpha Tau Medical was a new ETF Managers Group position in Q1 2023.
  • Alpha Tau Medical made up 0.01% of ETF Managers Group's portfolio in Q1 2023, its #588 holding.
  • ETF Managers Group first reported a position in Alpha Tau Medical in Q2 2022 and has held it in 3 quarters since.
  • ETF Managers Group's Alpha Tau Medical position peaked at $826K in Q2 2022.
  • 16 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.